Anna H. Turaj

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Sean H. Lim, Beth Stuart, Débora Joseph‐Pietras et al. · Nature Cancer · 2022 · 87 citations · Full text

Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment

Anna H. Turaj, Khiyam Hussain, Kerry L. Cox et al. · Cancer Cell · 2017 · 63 citations · Full text

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking

Anna H. Turaj, Kerry L. Cox, Christine A. Penfold et al. · Scientific Reports · 2018 · 46 citations · Full text

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

Thomas Cummin, Kerry L. Cox, Tom Murray et al. · Blood Advances · 2020 · 46 citations · Full text

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering

Franziska Heckel, Anna H. Turaj, Hayden Fisher et al. · Communications Biology · 2022 · 18 citations · Full text